Ebos Group Ltd Market Cap ($2.52 Billion)

$2.52 Billion USD  · AU$3.57 Billion AUD  · Rank #5268

Market Cap & Net Worth: Ebos Group Ltd (EBO)

Ebos Group Ltd market cap. Ebos Group Ltd (AU:EBO) has a market capitalization of $2.52 Billion (AU$3.57 Billion) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #5268 globally and #130 in its home market, demonstrating a 7.87% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ebos Group Ltd's stock price AU$17.40 by its total outstanding shares 205038721 (205.04 Million). Also see EBO cash generation efficiency for how efficiently the company converts equity into cash flow.

Ebos Group Ltd Market Cap History (2015–2026)

Ebos Group Ltd market cap history from 2015 to 2026. Data shows growth from $1.40 Billion to $2.52 Billion (5.80% CAGR). Check Ebos Group Ltd share price for real-time trading data and today's change.

Index Memberships

Ebos Group Ltd is a constituent of 3 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
Australia All Ordinaries
AORD
$2.05 Trillion 0.12% #112 of 495
S&P/ASX 300
AXKO
$2.21 Trillion 0.11% #117 of 300
ASX Small Ordinaries
AXSO
$292.22 Billion 0.86% #34 of 200

Weight: Ebos Group Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Ebos Group Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Ebos Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Ebos Group Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.26x

Ebos Group Ltd's market cap is 0.26 times its annual revenue

Industry average: 13.54x Lower than industry average

Latest Price to Earnings (P/E) Ratio

14.80x

Ebos Group Ltd's market cap is 14.80 times its annual earnings

Industry average: 65.33x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $1.84 Billion $7.10 Billion $127.00 Million 0.26x 14.47x
2017 $2.00 Billion $7.63 Billion $132.85 Million 0.26x 15.03x
2018 $2.41 Billion $7.61 Billion $149.56 Million 0.32x 16.13x
2019 $2.91 Billion $7.25 Billion $144.07 Million 0.40x 20.22x
2020 $3.50 Billion $9.38 Billion $173.95 Million 0.37x 20.11x
2021 $5.13 Billion $9.89 Billion $199.09 Million 0.52x 25.78x
2022 $5.61 Billion $11.90 Billion $224.64 Million 0.47x 24.96x
2023 $4.62 Billion $13.32 Billion $275.74 Million 0.35x 16.74x
2024 $4.93 Billion $14.41 Billion $296.71 Million 0.34x 16.62x
2025 $3.43 Billion $13.21 Billion $231.66 Million 0.26x 14.80x

Competitor Companies of EBO by Market Capitalization

Companies near Ebos Group Ltd in the global market cap rankings as of November 7, 2026. Also see Ebos Group Ltd asset portfolio for a full breakdown of the balance sheet.

Key companies related to Ebos Group Ltd by market ranking:

  • McKesson Corporation (NYSE:MCK): Ranked #245 globally with a market cap of $101.38 Billion USD.
  • Cencora Inc. (NYSE:COR): Ranked #446 globally with a market cap of $61.32 Billion USD.
  • Cardinal Health Inc (NYSE:CAH): Ranked #620 globally with a market cap of $43.01 Billion USD.
  • Sigma Healthcare Ltd (AU:SIG): Ranked #1123 globally with a market cap of $23.03 Billion USD ( AU$32.55 Billion AUD).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#245 McKesson Corporation NYSE:MCK $101.38 Billion $1072.00
#446 Cencora Inc. NYSE:COR $61.32 Billion $339.68
#620 Cardinal Health Inc NYSE:CAH $43.01 Billion $267.82
#1123 Sigma Healthcare Ltd AU:SIG $23.03 Billion AU$2.82

Market Capitalization of Ebos Group Ltd (2015–2026)

Market capitalization of Ebos Group Ltd from 2015 to today. Between 2015 and today, Ebos Group Ltd's market cap moved from $1.40 Billion to $ 2.52 Billion, with a yearly change of 5.80%.

Year Market Cap Change (%)
2026 AU$2.52 Billion -26.40%
2025 AU$3.43 Billion -30.45%
2024 AU$4.93 Billion +6.84%
2023 AU$4.62 Billion -17.68%
2022 AU$5.61 Billion +9.24%
2021 AU$5.13 Billion +46.75%
2020 AU$3.50 Billion +20.05%
2019 AU$2.91 Billion +20.73%
2018 AU$2.41 Billion +20.84%
2017 AU$2.00 Billion +8.69%
2016 AU$1.84 Billion +31.08%
2015 AU$1.40 Billion --

End of Day Market Cap According to Different Sources

On Nov 6th, 2026 the market cap of Ebos Group Ltd was reported to be:

Source Market Cap
Yahoo Finance $2.52 Billion USD
MoneyControl $2.52 Billion USD
MarketWatch $2.52 Billion USD
marketcap.company $2.52 Billion USD
Reuters $2.52 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Ebos Group Ltd

AU:EBO Australia Medical Distribution
Market Cap
$2.52 Billion
AU$3.57 Billion AUD
Market Cap Rank
#5268 Global
#130 in Australia
Share Price
AU$17.40
Change (1 day)
+1.40%
52-Week Range
AU$14.96 - AU$25.37
All Time High
AU$41.58
About

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligenc… Read more